关注
Raman Mahajan
Raman Mahajan
Médecins Sans Frontières / Doctors Without Borders
在 barcelona.msf.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Community-based management of severe acute malnutrition in India: new evidence from Bihar
S Burza, R Mahajan, E Marino, T Sunyoto, C Shandilya, M Tabrez, ...
The American journal of clinical nutrition 101 (4), 847-859, 2015
1122015
Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India
PK Sinha, J van Griensven, K Pandey, N Kumar, N Verma, R Mahajan, ...
Clinical Infectious Diseases 53 (7), e91-e98, 2011
992011
Combination treatment for visceral leishmaniasis patients coinfected with human immunodeficiency virus in India
R Mahajan, P Das, P Isaakidis, T Sunyoto, KD Sagili, MA Lima, G Mitra, ...
Clinical Infectious Diseases 61 (8), 1255-1262, 2015
762015
Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome)
S Burza, R Mahajan, PK Sinha, J van Griensven, K Pandey, MA Lima, ...
PLoS neglected tropical diseases 8 (8), e3053, 2014
712014
Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India
S Burza, PK Sinha, R Mahajan, MA Lima, G Mitra, N Verma, ...
PLoS neglected tropical diseases 8 (1), e2603, 2014
712014
Knowledge, attitudes, and practices related to antibiotic use in Paschim Bardhaman District: A survey of healthcare providers in West Bengal, India
M Nair, S Tripathi, S Mazumdar, R Mahajan, A Harshana, A Pereira, ...
PLoS One 14 (5), e0217818, 2019
702019
Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India
S Burza, PK Sinha, R Mahajan, MA Lima, G Mitra, N Verma, ...
PLoS neglected tropical diseases 8 (1), e2536, 2014
672014
HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination
S Burza, R Mahajan, MG Sanz, T Sunyoto, R Kumar, G Mitra, MA Lima
Clinical Infectious Diseases 59 (4), 552-555, 2014
612014
“Without antibiotics, I cannot treat”: A qualitative study of antibiotic use in Paschim Bardhaman district of West Bengal, India
M Nair, S Tripathi, S Mazumdar, R Mahajan, A Harshana, A Pereira, ...
PloS one 14 (6), e0219002, 2019
482019
Seasonal effect and long-term nutritional status following exit from a community-based management of severe acute malnutrition program in Bihar, India
S Burza, R Mahajan, E Marino, T Sunyoto, C Shandilya, M Tabrez, ...
European journal of clinical nutrition 70 (4), 437-444, 2016
442016
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India
S Burza, PK Sinha, R Mahajan, MG Sanz, MA Lima, G Mitra, N Verma, ...
PLoS neglected tropical diseases 8 (1), e2611, 2014
442014
Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis
R Nagill, R Mahajan, M Sharma, S Kaur
Parasitology International 58 (4), 359-366, 2009
342009
One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India
S Burza, E Nabi, R Mahajan, G Mitra, MA Lima
Clinical infectious diseases 57 (9), 1363-1364, 2013
242013
Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India
V Goyal, R Mahajan, K Pandey, SN Singh, RS Singh, N Strub-Wourgaft, ...
PLoS neglected tropical diseases 12 (10), e0006830, 2018
232018
Behavioural interventions to address rational use of antibiotics in outpatient settings of low‐income and lower‐middle‐income countries
MM Nair, R Mahajan, S Burza, MP Zeegers
Tropical Medicine & International Health 26 (5), 504-517, 2021
182021
AmBisome monotherapy and combination AmBisome–miltefosine therapy for the treatment of visceral leishmaniasis in patients coinfected with human immunodeficiency virus in India …
S Burza, R Mahajan, S Kazmi, N Alexander, D Kumar, V Kumar, E Lasry, ...
Clinical Infectious Diseases 75 (8), 1423-1432, 2022
172022
Standardized protocol items recommendations for observational studies (SPIROS) for observational study protocol reporting guidelines: protocol for a Delphi study
R Mahajan, S Burza, LM Bouter, K Sijtsma, A Knottnerus, J Kleijnen, ...
JMIR Research Protocols 9 (10), e17864, 2020
162020
Knowledge, attitudes, and practices regarding palliative care: a mixed-methods study from Bihar, India
M Nair, P Kumar, R Mahajan, A Harshana, KK Kurup, L Moreto-Planas, ...
Journal of Palliative Care 36 (1), 9-11, 2021
112021
Malnutrition in Chakradharpur, Jharkhand: an anthropological study of perceptions and care practices from India
I Chaand, M Horo, M Nair, A Harshana, R Mahajan, V Kashyap, F Falero, ...
BMC nutrition 5, 1-12, 2019
72019
Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, India
R Mahajan, SI Owen, S Kumar, K Pandey, S Kazmi, V Kumar, ER Adams, ...
Plos Neglected Tropical Diseases 16 (8), e0010718, 2022
52022
系统目前无法执行此操作,请稍后再试。
文章 1–20